Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel metal-free route for trifluoromethyl pyrazoles. Reduces cost and improves supply chain reliability for pharma intermediates. Efficient room temperature reaction.
Novel Pd-catalyzed carbonylation method for quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Novel heating-promoted synthesis eliminates metal catalysts for 2-trifluoromethyl quinoline. Offers green chemistry benefits and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.
Novel palladium-catalyzed method for pyrone derivatives. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.
Patent CN115785122A reveals a novel Lewis acid-catalyzed route to indole-piperidine scaffolds with high diastereoselectivity and potent MCF-7 cytotoxicity, offering a scalable solution for API manufacturing.
Patent CN102295638A details a novel one-pot method for Lapatinib synthesis, eliminating toxic tin reagents and improving purity for reliable API intermediate supply chains.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-one compounds offers high yield and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN115286553A reveals a novel nickel-catalyzed carbonylative cyclization for indole synthesis, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed method for high-purity pharmaceutical intermediates. Reduces steps and enhances supply chain reliability for global buyers seeking scalable solutions.
Novel Lewis acid catalyzed method for Meloxicam synthesis reduces reaction time and improves purity. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Patent CN118878543A reveals high-purity axial chiral synthesis with significant PC-3 cytotoxic activity and scalable catalytic asymmetric methods for supply chain optimization.
Patent CN113683595B reveals a sulfur-promoted synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN118126005B reveals metal-free synthesis for fluorinated intermediates. Enables cost reduction and scalable supply for pharmaceutical manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chains.
Patent CN113045503A details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and simplified purification for API manufacturing.
Patent CN110194760B reveals a one-pot Pd-catalyzed route for isoindolinone intermediates, offering high yields and simplified supply chains for API manufacturing.
Patent CN113735756B reveals high-yield rhodium catalysis for chiral isoindolinones. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.